Dr Jessica Borger completed her Bachelor of Medical and Pharmaceutical Biotechnology (Honours) at the University of South Australia then moved to the UK and completed a prestigious Medical Research Council PhD scholarship at the National Institute of Medical Research awarded through University College London. In Prof Rose Zamoyska's laboratory she investigated the localisation of cell surface receptors and intracellular proximal TCR signaling molecules in CD8 T cells during memory formation. Jessica's MRC postdoctoral research from 2010-2016 at the University of Edinburgh, Scotland with Prof Zamoyska involved investigating the novel role of Caveolin-1 in T cell cholesterol homeostasis, integrin signaling and exosome biogenesis. In 2016, Jessica returned to Australia as a senior postdoctoral researcher at the Central Clinical School at Monash University in Ass. Prof. Margaret Hibbs laboratory. Dr Borger's research interests include the design of novel CAR-T therapy approaches in the lung using novel intracellular checkpoint blockade targets (CASS Foundation Medicine/Science grant) as well as investigating the signaling pathways of unconventional T cells and their contribution to inflammation in models of pulmonary disease. In 2019 Dr Borger became a lecturer and course co-ordinator of graduate studies, establishing a Master's course in Translational Research and Medicine at the Central Clinical School.

Dr Borger also works as News and Commentary Editor for Immunology & Cell Biology, Topic Editor for Frontiers in Immunology and is a reveiwer for Immunology & Cell Biology, Clincial & Translational Immunology, Scientific Reports, Frontiers in Immunology, Bioessays and the International Journal of Molecular Medicine. Dr Borger serves on the executive committee of the Victorian Infection and Immunity Network and the Lorne Infection and Immunity Conference, is Secretary on the Australia and New Zealand Society of Immunology Advanced Immunology School, is a committee member on the Gender Equity Diversity and Inclusion commitee of the Central Clinical School at Monash University and the A+ Gender Equity committee of the A+ Alfred Research Alliance.  Dr Borger was awarded a prestigious Veski Inspiring women STEM sidebyside scholarship for mid-career emerging leaders, nominated for The Times 100 Women of Influence Award 2019 and was the inaugural recipient of the Margaret Baird Women in Immunology Award from the Australia and New Zealand Society of Immunology (2019). Dr Borger writes for The Conversation, Women in STEMM Australia and Women's Agenda.